Seventy-six percent of patients had at least one pre-existing comorbidity; the most frequent ones were arterial hypertension, cardiovascular disease and diabetes mellitus; 499 (30.6%) patients were on chronic therapy with angiotensin-converting enzyme (ACE) and/or angiotensin-II inhibitors. This evidence concerns the gene ACE and cardiovascular disorder.